In lung cancer, the inhibition of SOX18 with a specific inhibitor called Sm4 has shown cytotoxic effects on non-small cell lung cancer (NSCLC) cell lines, leading to cell cycle disruption and up-regulation of p21, a key regulator of cell cycle progression [66]. This evidence concerns the gene SOX18 and non-small cell lung carcinoma.